ArticleOncoimmunology2022

Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response.

Chuan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.